• N/A
    Market Cap
  • -82.01%
    1-Year Change
  • Biotechnology
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: N/A
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

No data found

No data found

Peers

Statistics

More
Day Range
$1.02
$1.02
$1.02
1-Year Range
$1.00
$5.00
$1.02
Latest Close$1.02
Change
-$0.77 (-75.49%)
Volume222

Information as of 07/27/2026

Company Profile

N/A
Market Cap
N/A
Net Income
Sector: Healthcare
Industry: Biotechnology
19125 Northcreek Parkway, Bothell, WA, United States, 98011
425 402 8400

Helix BioMedix, Inc., a biotechnology company, develops peptide-based therapeutics for dermatology and skin health in the United States. It is developing HB4208 for treatment of the rare disease Xeroderma Pigmentosum; and BIOACTIVE SMARTPEPTIDES, a bioactive peptide ingredient for skin care companies. The company was founded in 1988 and is based in Bothell, Washington.

Key Executives

  • Robin L. Carmichael

Current Ownership Distribution

  • Other134,721 (59.95%)
  • Insiders89,987 (40.05%)
  • Institutions0 (0.00%)
  • Mutual Funds0 (0.00%)